Imaging and Spectroscopic Analysis of Living Cells: Imaging and Spectroscopic Analysis of Living Cells: Volume 3 Volume 506
18%
off

Imaging and Spectroscopic Analysis of Living Cells: Imaging and Spectroscopic Analysis of Living Cells: Volume 3 Volume 506 : Imaging Live Cells in Health and Disease

Volume editor  , Volume editor 

Free delivery worldwide

Available. Dispatched from the UK in 3 business days
When will my order arrive?

Description

This volume of Methods in Enzymology is the third of 3 parts looking at current methodology for the imaging and spectroscopic analysis of live cells. The chapters provide hints and tricks not available in primary research publications. It is an invaluable resource for academics, researchers and students alike.
show more

Product details

  • Hardback | 544 pages
  • 154.94 x 231.14 x 33.02mm | 975.22g
  • Academic Press Inc
  • San Diego, United States
  • English
  • 0123918561
  • 9780123918567
  • 2,116,437

Table of contents

Part A: Viruses, Microbes and Parasites

Nanoscale imaging of microbial pathogens using atomic force microscopy

Challenges in imaging parasites

Part B: Disease States Real-time live imaging to study bacterial infections in vivo

Analysis of cellular membrane dynamics by following virus endocytosis

Imaging of live malaria blood stage parasites

Escherichia coli K1 invasion of human brain microvascular endothelial cells

Real-time imaging after cerebral ischemia

Imaging acute inflammation in zebrafish

Imaging protein oligomerization in neurodegeneration using BiEC

Imagng and quantifying the dyanmics of tumor-associated proteolysis

Part C: Other Techniques

Live cell imaging in vivo with fluorescent proteins

Visualization of gene expression

Imaging stem cell implant for cellular-based therapies

Live cell single molecule imaging to investigate early events in B lymphocyte signaling

A quantitative method for measuring phototoxicity of a live cell imaging microscope

High content screening of defined chemical libraries using normal and glioma-derived neural stem cell lines

High-content screening of primary neurons

Live-imaging fluorescent proteins in early mouse embryos

Comparing the methods for quantitative analysis of dendritic spine dynamics

Live-imaging of cell competition in drosophila imaginal epithelium

Live cell imaging of the oviduct

Computational estimation of leukocyte numbers in zebrafish

Four dimensional tracking of lymphocyte migration and interactions by two-photon microscopy
show more

About Dr. P. Michael Conn

P. Michael Conn is the Senior Vice President for Research and Associate Provost, Texas Tech Health Sciences Center. He is The Robert C. Kimbrough, Professor of Internal Medicine and Cell Biology/Biochemistry. He was previously Director of Research Advocacy and Professor of Physiology and Pharmacology, Cell Biology and Development and Obstetrics and Gynecology at Oregon Health and Science University and Senior Scientist of the Oregon National Primate Research Center (ONPRC). He served for twelve years as Special Assistant to the President and Associate Director of the ONPRC. After receiving a B.S. degree and teaching certification from the University of Michigan (1971), a M.S. from North Carolina State University (1973), and a Ph.D. degree from Baylor College of Medicine (1976), Conn did a fellowship at the NIH, then joined the faculty in the Department of Pharmacology, Duke University Medical Center where he was promoted to Associate Professor in 1982. In 1984, he became Professor and Head of Pharmacology at the University of Iowa College of Medicine, a position he held for eleven years. Conn is known for his research in the area of the cellular and molecular basis of action of gonadotropin releasing hormone action in the pituitary and therapeutic approaches that restore misfolded proteins to function. His work has led to drugs that have benefitted humans and animals. Most recently, he has identified a new class of drugs, pharmacoperones, which act by regulating the intracellular trafficking of receptors, enzymes and ion channels. He has authored or co-authored over 350 publications in this area and written or edited over 200 books, including texts in neurosciences, molecular biology and endocrinology. Conn has served as the editor of many professional journals and book series (Endocrinology, Journal of Clinical Endocrinology and Metabolism, Endocrine, Methods, Progress in Molecular Biology and Translational Science and Contemporary Endocrinology). Conn served on the National Board of Medical Examiners, including two years as chairman of the reproduction and endocrinology committee. The work of his laboratory has been recognized with a MERIT award from the NIH, the J.J. Abel Award of the American Society for Pharmacology and Experimental Therapeutics, the Weitzman, Oppenheimer and Ingbar Awards of the Endocrine Society, the National Science Medal of Mexico (the Miguel Aleman Prize) and the Stevenson Award of Canada. He is the recipient of the Oregon State Award for Discovery, the Media Award of the American College of Neuropsychopharmacology and was named a distinguished Alumnus of Baylor College of Medicine in 2012. Conn is a previous member of Council for the American Society for Cell Biology and the Endocrine Society and is a prior President of the Endocrine Society, during which time he founded the Hormone Foundation and worked with political leadership to heighten the public's awareness of diabetes. Conn's students and fellows have gone on to become leaders in industry and academia. He is an elected member of the Mexican Institute of Medicine and a fellow of the American Association for the Advancement of Science. He is the co-author of The Animal Research War (2008) and many articles for the public and academic community on the value of animal research and the dangers posed by animal extremism. His op/eds have appeared in The Washington Post, The LA Times, The Wall Street Journal, the Des Moines Register, and elsewhere. Conn consults with organizations that are influenced by animal extremism and with universities and companies facing challenges from these groups.
show more